[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355090-105":59,"doc-detail-355090-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","tumor-cell-cycle-regulation-integrated-perspective-of-stage-characteristics-regulatory-networks-and-signaling-pathway-intervention-strategies","Tumor cell cycle regulation - integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies","","Dysregulation of the cell cycle is a core driver of tumorigenesis and makes cell cycle regulators promising antitumor targets. This review synthesizes up-to-date mechanistic insights and translational relevance in oncology by detailing the cyclin–CDK–CKI axis, tumor cell cycle regulatory mechanisms across transcriptional control, post-translational modifications, checkpoints, crosstalk, and key signaling pathways. It also highlights clinically relevant biomarkers and assesses approved and trial-stage cell cycle–targeting agents and related metabolic pathway interventions, while addressing barriers to clinical translation and calling for multi-omics and systems biology approaches.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/tumor-cell-cycle-regulation-integrated-perspective-of-stage-characteristics-regulatory-networks-and-signaling-pathway-intervention-strategies/355090/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/tumor-cell-cycle-regulation-integrated-perspective-of-stage-characteristics-regulatory-networks-and-signaling-pathway-intervention-strategies/355090.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"为什么细胞周期失调与肿瘤发生密切相关？","Question",{"text":112,"@type":113},"细胞周期失调是肿瘤发生的基础机制之一。综述指出，细胞周期相关调控因子因此成为潜在的抗肿瘤治疗靶点。","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"综述主要从哪些角度解析肿瘤细胞周期调控？",{"text":117,"@type":113},"从转录调控、翻译后修饰、检查点机制、与细胞过程的交叉联系以及关键信号通路的整合等多视角展开。",{"name":119,"@type":110,"acceptedAnswer":120},"治疗方面，文中如何评估干预策略与临床前景？",{"text":121,"@type":113},"综述围绕已获批的治疗药物与临床试验中的天然化合物，综合评估靶向细胞周期及相关代谢通路的现有治疗思路，并讨论其在精准肿瘤学中的前景。同时指出仍存在肿瘤特异网络理解不足和临床转化障碍等挑战。","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355090,1790294220,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Wan etal. Molecular Biomedicine (2026) 7:14 [https://doi.org/10.1186/s43556-026-00411-w](https://doi.org/10.1186/s43556-026-00411-w)  \nMolecular Biomedicine  \n REVIEW Open Access  \nTumor cell cycle regulation: integrated  \nperspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies  \nQing Wan1†, Zhongmin Yang3†, Lian Huang1, Yang Xia6, Lihua Long7, Zucai Xu4,5* and Jida Li 1,2*  \nAbstract  \nDysregulation of the cell cycle is one of the fundamental mechanisms underlying tumorigenesis, making cell cyclerelated regulators potential antitumor therapeutic targets. Despite significant advances in understanding cell cycle regulatory networks, there is still a lack of a comprehensive and up-to-date synthesis that integrates the latest mechanistic insights with their translational potential in oncology. This review first systematically outlines the pivotal role of the cyclin-cyclin-dependent kinase (CDK)-cyclin-dependent kinase inhibitor (CKI) axis in driving aberrant cell cycle progression in tumors. Then the complex regulatory mechanisms ofthe tumor cell cycle were explored from various perspectives, including transcriptional control, post-translational modifications, checkpoint mechanisms, crosstalk with cellular processes, and integration with key signaling pathways. Furthermore, we highlight a series of clinically relevant biomarkers tightly linked to cell cycle dysregulation. Focusing on approved therapeutic agents and natural compounds in clinical trials, current treatment approaches that target the cell cycle and related metabolic pathways were also comprehensively assessed, and their prospects in precision oncology were elaborated. Finally, we discuss persistent challenges, including the incomplete understanding of tumor-specific cell cycle networks and the barriers to the clinical translation of targeted therapies. We advocate for future research to leverage multi-omics integration and systems biology approaches to facilitate more precise and effective cell cycle-directed interventions. This work offers a comprehensive framework that connects the fundamental mechanisms of cell cycle dysregulation in tumors with clinical translation, aiming to accelerate biomarker discovery and the development of next-generation precision oncology strategies.  \nKeywords Cell cycle dysregulation, Cell cycle regulatory network, Precision biomarkers, Targeted intervention strategies, Tumor therapy  \n†Qing Wan and Zhongmin Yang contributed equally to this work and should be considered co-first authors.  \n*Correspondence: Zucai Xu [docxzc@126.com](docxzc@126.com)[ ](docxzc@126.com)Jida Li[lijida198485@163.com](lijida198485@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nWan etal. Molecular Biomedicine (2026) 7:14  \nIntroduction  \nThe cell cycle is a tightly controlled, highly ordered series of biological processes that results in cellular proliferation by producing genetically identical daughter cells through mitosis","cbCaidp1x2EYGk0c","https://ap.wps.com/l/cbCaidp1x2EYGk0c","pdf",5963318,38,"English","# Introduction\n# Abstract\n## Tumor cell cycle regulation overview\n## Translational strategies and challenges","[{\"question\":\"为什么细胞周期失调与肿瘤发生密切相关？\",\"answer\":\"细胞周期失调是肿瘤发生的基础机制之一。综述指出，细胞周期相关调控因子因此成为潜在的抗肿瘤治疗靶点。\"},{\"question\":\"综述主要从哪些角度解析肿瘤细胞周期调控？\",\"answer\":\"从转录调控、翻译后修饰、检查点机制、与细胞过程的交叉联系以及关键信号通路的整合等多视角展开。\"},{\"question\":\"治疗方面，文中如何评估干预策略与临床前景？\",\"answer\":\"综述围绕已获批的治疗药物与临床试验中的天然化合物，综合评估靶向细胞周期及相关代谢通路的现有治疗思路，并讨论其在精准肿瘤学中的前景。同时指出仍存在肿瘤特异网络理解不足和临床转化障碍等挑战。\"}]","Tumor cell cycle regulation - integrated perspective of stage characteristics, regulatory networks, and signaling pathway intervention strategies | PDF",1790115894,96,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/961e00bede17a60011d416a0476ec193.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/25cfaa5104883e80a23d45885a1667db.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be066a5dfa73394e153a139a9a571a2f.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/250ccb0d986ba0bfa5f908f92158e6fe.webp",980,1301]